These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30267650)

  • 41. Anti-cancer activity of asiatic acid against human cholangiocarcinoma cells through inhibition of proliferation and induction of apoptosis.
    Sakonsinsiri C; Kaewlert W; Armartmuntree N; Thanan R; Pakdeechote P
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):28-33. PubMed ID: 30084792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest.
    Li Z; Yu Y; Sun S; Qi B; Wang W; Yu A
    Oncol Rep; 2015 Apr; 33(4):1763-8. PubMed ID: 25634333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel derivative of quinazoline, WYK431 induces G2/M phase arrest and apoptosis in human gastric cancer BGC823 cells through the PI3K/Akt pathway.
    Wang TE; Wang YK; Jin J; Xu BL; Chen XG
    Int J Oncol; 2014 Aug; 45(2):771-81. PubMed ID: 24859921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
    Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
    Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
    Yin Y; Zhang M; Dorfman RG; Li Y; Zhao Z; Pan Y; Zhou Q; Huang S; Zhao S; Yao Y; Zou X
    Cell Death Dis; 2017 Jun; 8(6):e2856. PubMed ID: 28569784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel Synthetic Mono-triazole Glycosides Induce G0/G1 Cell-cycle Arrest and Apoptosis in Cholangiocarcinoma Cells.
    Obchoei S; Saeeng R; Wongkham C; Wongkham S
    Anticancer Res; 2016 Nov; 36(11):5965-5973. PubMed ID: 27793922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1‑related anti‑apoptotic proteins.
    Saranaruk P; Kariya R; Sittithumcharee G; Boueroy P; Boonmars T; Sawanyawisuth K; Wongkham C; Wongkham S; Okada S; Vaeteewoottacharn K
    Int J Mol Med; 2020 Apr; 45(4):1005-1016. PubMed ID: 32124934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
    Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V
    Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
    Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
    Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
    Fang C; Zhang J; Qi D; Fan X; Luo J; Liu L; Tan Q
    PLoS One; 2014; 9(12):e115204. PubMed ID: 25506932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives.
    Latif AD; Gonda T; Vágvölgyi M; Kúsz N; Kulmány Á; Ocsovszki I; Zomborszki ZP; Zupkó I; Hunyadi A
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α-Carboline derivative TJY-16 inhibits tumor growth by inducing G2/M cell cycle arrest in glioma cells.
    Huang HC; Liu WT; Hua KS; Hung HC; Tsai JY; Kuo SC; Huang LJ; Gean PW
    J Biomed Sci; 2016 Jan; 23():10. PubMed ID: 26786523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methyl Sartortuoate Inhibits Colon Cancer Cell Growth by Inducing Apoptosis and G2/M-Phase Arrest.
    Lan Q; Li S; Lai W; Xu H; Zhang Y; Zeng Y; Lan W; Chu Z
    Int J Mol Sci; 2015 Aug; 16(8):19401-18. PubMed ID: 26287184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of G2/M phase arrest and apoptosis by a new tetrahydroingenol diterpenoid from Euphorbia erythradenia Bioss. in melanoma cancer cells.
    Fallahian F; Ghanadian M; Aghaei M; Zarei SM
    Biomed Pharmacother; 2017 Feb; 86():334-342. PubMed ID: 28011381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
    Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
    Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The anticancer effects of Resina Draconis extract on cholangiocarcinoma.
    Wen F; Zhao X; Zhao Y; Lu Z; Guo Q
    Tumour Biol; 2016 Nov; 37(11):15203-15210. PubMed ID: 27683055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondrial division inhibitor-1 potentiates cisplatin-induced apoptosis via the mitochondrial death pathway in cholangiocarcinoma cells.
    Tusskorn O; Khunluck T; Prawan A; Senggunprai L; Kukongviriyapan V
    Biomed Pharmacother; 2019 Mar; 111():109-118. PubMed ID: 30579250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five-(Tetradecyloxy)-2-furoic Acid Alleviates Cholangiocarcinoma Growth by Inhibition of Cell-cycle Progression and Induction of Apoptosis.
    Boonnate P; Kariya R; Saranaruk P; Cha'on U; Sawanyawisuth K; Jitrapakdee S; Okada S; Vaeteewoottacharn K
    Anticancer Res; 2021 Jul; 41(7):3389-3400. PubMed ID: 34230134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients.
    Cheng CT; Chen YY; Wu RC; Tsai CY; Chiang KC; Yeh TS; Chen MH; Yeh CN
    Oncol Rep; 2018 Sep; 40(3):1411-1421. PubMed ID: 30015968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.